cRGD, Flamma® 774

Catalog No. ARW1601


Lead time
0.5 mg $103.00
1 mg $192.00
5 mg $676.00
  • option




cRGD, Flamma® 774 is an angiogenesis imaging fluorescent probe, made up of a covalent-connection of cyclic RGD with Flamma® 774. Cyclic RGD binds preferentially to αvβ3 integrin with high affinity. Integrin αvβ3 is known to strongly involve in the regulation of angiogenesis. The αvβ3 is generally expressed in low levels on the epithelial cells and mature endothelial cells, but it is highly expressed in many solid tumors. Cyclic RGD peptides are also able to bind αvβ5, α5β1, α6β4, α4β1, and αvβ6 integrins, which may help enhance their tumor uptake due to the increased receptor population. We offer cRGD, Flamma® 774 as in vivo fluorescent probes for imaging of blood vessels, tumors and angiogenesis. 


Fluorophore: Flamma® 774
Application: Angiogenesis imaging
Excitation/Emission Max.(nm): 774/806 nm
Molecular weight: 1528.75 g/mol
Appearance: Green Solid
Storage conditions: -20 ℃, protect from light

Citation & Reference

1. Yumin Zheng. FITC-Conjugated Cyclic RGD Peptides as Fluorescent Probes for Staining Integrin αvβ3/αvβ5 in Tumor Tissues. Bioconjug Chem 25.1 (2014): 1925-41.

2. Dongfang Yue. Biomarker-targeted fluorescent probes for breast cancer imaging. Chinese Chemical Letters 29.5 (2018): 648-656.


Added cart

장바구니 아이콘

We put the items
in the shopping cart.